High-fat diet protects the blood-brain barrier in an Alzheimer's disease mouse model

被引:39
|
作者
Goldman, Shirin Elhaik [1 ,2 ]
Goez, David [3 ]
Last, David [3 ]
Naor, Sharone [1 ]
Zaltsman, Sigal Liraz [1 ,4 ]
Sharvit-Ginon, Inbal [1 ,5 ]
Atrakchi-Baranes, Dana [1 ]
Shemesh, Chen [1 ]
Twitto-Greenberg, Rachel [1 ,6 ]
Tsach, Shoval [1 ]
Lotan, Roni [1 ]
Leikin-Frenkel, Alicia [6 ,7 ]
Shish, Aviv [6 ]
Mardor, Yael [3 ,7 ]
Beeri, Michal Schnaider [1 ,8 ,9 ]
Cooper, Itzik [1 ,9 ]
机构
[1] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, IL-52621 Ramat Gan, Israel
[2] Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel
[3] Sheba Med Ctr, Adv Technol Ctr, Ramat Gan, Israel
[4] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med,Pharmacol Div, Jerusalem, Israel
[5] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel
[6] Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Ramat Gan, Israel
[7] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[8] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA
[9] Interdisciplinary Ctr, Herzliyya, Israel
关键词
Alzheimer's disease; amyloid beta; blood-brain barrier; cholesterol; high-fat diet; insulin resistance; MRI; Tg2576; mice; INSULIN-RESISTANCE; DIABETES-MELLITUS; TRANSGENIC MICE; RISK; POPULATION; DEMENTIA; MEMORY; HDL; NEURODEGENERATION; PERMEABILITY;
D O I
10.1111/acel.12818
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Type 2 diabetes (T2D) is associated with increased risk of Alzheimer's disease (AD). There is evidence for impaired blood-brain barrier (BBB) in both diseases, but its role in the interplay between them is not clear. Here, we investigated the effects of high-fat diet (HFD), a model for T2D, on the Tg2576 mouse model of AD, in regard to BBB function. We showed that HFD mice had higher weight, more insulin resistance, and higher serum HDL cholesterol levels, primarily in Tg2576 mice, which also had higher brain lipids content. In terms of behavior, Tg2576 HFD mice were less active and more anxious, but had better learning in the Morris Water Maze compared to Tg2576 on regular diet. HFD had no effect on the level of amyloid beta 1-42 in the cortex of Tg2576 mice, but increased the transcription level of insulin receptor in the hippocampus. Tg2576 mice on regular diet demonstrated more BBB disruption at 8 and 12 months accompanied by larger lateral ventricles volume in contrast to Tg2576 HFD mice, whose BBB leakage and ventricular volume were similar to wild-type (WT) mice. Our results suggest that in AD, HFD may promote better cognitive function through improvements of BBB function and of brain atrophy but not of amyloid beta levels. Lipid metabolism in the CNS and peripheral tissues and brain insulin signaling may underlie this protection.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease
    Rofo, Fadi
    Metzendorf, Nicole G.
    Saubi, Cristina
    Suominen, Laura
    Godec, Ana
    Sehlin, Dag
    Syvanen, Stina
    Hultqvist, Greta
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [32] High-Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer's Disease
    Bosoi, Cristina R.
    Vandal, Milene
    Tournissac, Marine
    Leclerc, Manon
    Fanet, Hortense
    Mitchell, Patricia L.
    Verreault, Melanie
    Trottier, Jocelyn
    Virgili, Jessica
    Tremblay, Cynthia
    Lippman, H. Robert
    Bajaj, Jasmohan S.
    Barbier, Olivier
    Marette, Andre
    Calon, Frederic
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (03) : 446 - 460
  • [33] Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease
    Gosselet, Fabien
    Saint-Pol, Julien
    Fenart, Laurence
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 446 (03) : 687 - 691
  • [34] Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease
    Wisniewski, HM
    Vorbrodt, AW
    Wegiel, J
    CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 : 161 - 172
  • [35] Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
    Bell, Robert D.
    Zlokovic, Berislav V.
    ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 103 - 113
  • [36] Alzheimer's disease: future drug development and the blood-brain barrier
    Pardridge, William M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 569 - 572
  • [37] Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
    Gosselet, Fabien
    Saint-Pol, Julien
    Candela, Pietra
    Fenart, Laurence
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (10) : 1015 - 1033
  • [38] Transport of drugs across the blood-brain barrier in Alzheimer's disease
    Nicolazzo, Joseph A.
    Mehta, Dharmini C.
    THERAPEUTIC DELIVERY, 2010, 1 (04) : 595 - 611
  • [39] Dyslipidemia in Alzheimer's Disease Is Associated with Blood-Brain Barrier Impairment
    Bowman, Gene L.
    Kaye, Jeffery A.
    Quinn, Joseph F.
    NEUROLOGY, 2010, 74 (09) : A137 - A137
  • [40] Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease
    Erickson, Michelle A.
    Banks, William A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (10): : 1500 - 1513